Table 2 Contingency matrices for the test set of the (A) research assay and (B) InSignia assay, defining the true positive, true negative, false positive, and false negative rates for detecting viral infection, with reference to the clinical respiratory pathogen panel as the ‘gold standard’ (n = 38).
(A) | Respiratory pathogen panel | (B) | Respiratory pathogen panel | ||||
|---|---|---|---|---|---|---|---|
Research assay | Viral | Non-viral | Total | InSignia assay | Viral | Non-viral | Total |
Viral | 22 (TP) | 0 (FP) | 22 | Viral | 27 (TP) | 0 (FP) | 27 |
Non-viral | 7 (FN) | 9 (TN) | 16 | Non-viral | 2 (FN) | 9 (TN) | 11 |
Total | 29 | 9 | 38 | Total | 29 | 9 | 38 |
